Alkermes (ALKS) Cash & Current Investments (2010 - 2026)
Alkermes' Cash & Current Investments came in at $656.58 million for Q2 2026, down 35.4% from $1.02 billion a year earlier but up 28.3% from the prior quarter.
Alkermes (ALKS) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Alkermes' Cash & Current Investments was $588.22 million, down 21.7% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $751.67 million in FY2024 (-2.8%), $773.49 million in FY2023 (+27.1%), $608.47 million in FY2022 (+13.5%) and $536.31 million in FY2021 (-15.5%).
- The five-year range for quarterly Cash & Current Investments is $511.86 million (Q1 2026) to $1.11 billion (Q3 2025).
- Year-over-year, Cash & Current Investments has declined for three consecutive quarters, with an average decline of 5.4% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q3 2023 (growth of 53.3%), and the weakest in Q1 2026 (a decline of 42.1%).
- Business Quant data shows ALKS's Cash & Current Investments at $511.86 million (Q1 2026), $588.22 million (Q4 2025) and $1.11 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Alkermes | 6.99 Bn | 4.13 Bn | 397.90 Mn | 656.58 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 656.58 Mn |
| Mar 31, 2026 | 511.86 Mn |
| Dec 31, 2025 | 588.22 Mn |
| Sep 30, 2025 | 1.11 Bn |
| Jun 30, 2025 | 1.02 Bn |
| Mar 31, 2025 | 884.02 Mn |
| Dec 31, 2024 | 751.67 Mn |
| Sep 30, 2024 | 908.86 Mn |
| Jun 30, 2024 | 876.12 Mn |
| Mar 31, 2024 | 745.05 Mn |
| Dec 31, 2023 | 773.49 Mn |
| Sep 30, 2023 | 889.15 Mn |
| Jun 30, 2023 | 829.05 Mn |
| Mar 31, 2023 | 600.46 Mn |
| Dec 31, 2022 | 608.47 Mn |
| Sep 30, 2022 | 580.18 Mn |
| Jun 30, 2022 | 580.97 Mn |
| Mar 31, 2022 | 528.87 Mn |
| Dec 31, 2021 | 536.31 Mn |
| Sep 30, 2021 | 560.30 Mn |
Alkermes Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ALKS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();